Abstract

INDIAN PHARMACEUTICALS IN EMERGING AFRICAN ECONOMY

Ku. Sadhvi Tiwari* and Amitkumar Patel

Abstract

India being a global provider of Generic medicines at a competitive price will escalate its market to more than US$38.3 Billion by 2022. India should focus on leveraging its pharma export by strengthening its position in market and making long term strategy. Main aim of this review is to analyse market potential of Indian Pharmaceuticals in Emerging African Economy, especially Nigeria, Egypt and Tanzania. Regulatory Norms for Market Authorization is discussed in brief to create awareness in stakeholders associated with trade of pharmaceuticals alert of regulatory procedures in these countries. This review focuses on exploring trade opportunities in such African Economies. PESTEL Analysis is done to analyse, economic and trade indicators. Regulatory norms of these three countries are discussed for export and marketing. SWOT Analysis indicates higher profit if distribution of pharmaceuticals are protected from being counterfeit, which is prevalent in these nations. Exporting Anti-infective and Anti-malarial drugs would give major profit in such regions.

Keywords: Market potential, trade opportunities, regulatory norms, trade indicators, PESTEL analysis, and SWOT analysis.